These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28243732)

  • 1. Decreased Endothelial Progenitor Cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis.
    Laganà AS; Giordano D; Loddo S; Zoccali G; Vitale SG; Santamaria A; Buemi M; D'Anna R
    Arch Gynecol Obstet; 2017 Apr; 295(4):867-872. PubMed ID: 28243732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD-34
    Brown N; Khan F; Alshaikh B; Berka N; Liacini A; Alawad E; Yusuf K
    Pregnancy Hypertens; 2019 Apr; 16():42-47. PubMed ID: 31056159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of decidual NK cells and KIR genotypes in healthy pregnant and preeclamptic women: a case-control study in the third trimester of gestation.
    Sánchez-Rodríguez EN; Nava-Salazar S; Mendoza-Rodríguez CA; Moran C; Romero-Arauz JF; Ortega E; Granados J; Cervantes-Peredo A; Cerbón M
    Reprod Biol Endocrinol; 2011 Jan; 9():8. PubMed ID: 21247496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133+/C-kit+Lin
    Park Y; Lee HJ; Jung YJ; Kwon HY; Kim H; Lee J; Kim YH; Kim HO; Maeng YS; Kwon JY
    Pregnancy Hypertens; 2019 Jan; 15():146-153. PubMed ID: 30825912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia.
    Luppi P; Powers RW; Verma V; Edmunds L; Plymire D; Hubel CA
    Reprod Sci; 2010 Jul; 17(7):643-52. PubMed ID: 20360595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer Cells Contribute to Pathogenesis of Severe Alcoholic Hepatitis by Inducing Lysis of Endothelial Progenitor Cells.
    Sehgal R; Kaur S; Shasthry SM; Agrawal T; Dwivedi V; Seth D; Ramakrishna G; Sarin SK; Trehanpati N
    Alcohol Clin Exp Res; 2020 Jan; 44(1):78-86. PubMed ID: 31746472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in endothelial progenitor cell subsets in normal pregnancy compared with preeclampsia.
    Parsanezhad ME; Attar A; Namavar-Jahromi B; Khoshkhou S; Khosravi-Maharlooei M; Monabati A; Habibagahi M
    J Chin Med Assoc; 2015 Jun; 78(6):345-52. PubMed ID: 26006732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High first-trimester maternal blood cystatin C levels despite normal serum creatinine predict pre-eclampsia in singleton pregnancies.
    Risch M; Purde MT; Baumann M; Mohaupt M; Mosimann B; Renz H; Raio L; Surbek D; Risch L
    Scand J Clin Lab Invest; 2017 Dec; 77(8):634-643. PubMed ID: 29069989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells in the pathogenesis of preeclampsia: a double-edged sword.
    Du M; Wang W; Huang L; Guan X; Lin W; Yao J; Li L
    J Matern Fetal Neonatal Med; 2022 Mar; 35(6):1028-1035. PubMed ID: 32188324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
    Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia.
    Ben Ali Gannoun M; Bourrelly S; Raguema N; Zitouni H; Nouvellon E; Maleh W; Brahim Chemili A; Elfeleh R; Almawi W; Mahjoub T; Gris JC
    Cytokine; 2016 Mar; 79():1-6. PubMed ID: 26702929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased proportion of peripheral blood vascular endothelial growth factor-expressing T and natural killer cells in preeclampsia.
    Molvarec A; Ito M; Shima T; Yoneda S; Toldi G; Stenczer B; Vásárhelyi B; Rigó J; Saito S
    Am J Obstet Gynecol; 2010 Dec; 203(6):567.e1-8. PubMed ID: 20833383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased secretory sphingomyelinase activity in the first trimester of pregnancy in women later developing preeclampsia: a nested case-control study.
    Rodríguez-Sureda V; Crovetto F; Triunfo S; Sánchez O; Crispi F; Llurba E; Gratacós E; Figueras F; Domínguez C
    Biol Chem; 2016 Mar; 397(3):269-79. PubMed ID: 26756094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.
    Dobierzewska A; Soman S; Illanes SE; Morris AJ
    PLoS One; 2017; 12(4):e0175118. PubMed ID: 28384202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy.
    Parra-Cordero M; Rodrigo R; Barja P; Bosco C; Rencoret G; Sepúlveda-Martinez A; Quezada S
    Ultrasound Obstet Gynecol; 2013 May; 41(5):538-44. PubMed ID: 22807133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of preeclampsia and intrauterine growth restriction on endothelial progenitor cells in human umbilical cord blood.
    Monga R; Buck S; Sharma P; Thomas R; Chouthai NS
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2385-9. PubMed ID: 22640270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prevalence of peripheral blood granulysin-producing cytotoxic T lymphocytes in preeclampsia.
    Molvarec A; Shiozaki A; Ito M; Toldi G; Stenczer B; Szarka A; Nakashima A; Vásárhelyi B; Rigó J; Saito S
    J Reprod Immunol; 2011 Sep; 91(1-2):56-63. PubMed ID: 21763002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia.
    Fukui A; Funamizu A; Yokota M; Yamada K; Nakamua R; Fukuhara R; Kimura H; Mizunuma H
    J Reprod Immunol; 2011 Jun; 90(1):105-10. PubMed ID: 21632120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.